1 |
0.9% physiological saline |
- |
- |
- |
- |
266 [1] 266 💬 |
2 |
Acz885 |
- |
- |
- |
- |
046 [7] 46, 84, 106, 107, 108, 266, 267 💬 |
3 |
Acz885, 150mg/1.0ml |
- |
- |
- |
- |
266 [2] 266, 267 💬 |
4 |
Canakinumab |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
5 |
Colchicine |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [7] 2 , 42, 46, 56, 93, 210, 266 💬 |
6 |
Colchicine sprinkle capsules |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
7 |
Diagnostic test: colchicine level measurement |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
8 |
Il-1 trap |
- |
- |
- |
- |
266 [1] 266 💬 |
9 |
Ilaris |
- |
- |
- |
- |
056 [7] 56, 84, 106, 107, 108, 266, 267 💬 |
10 |
Inn-tocilizumab |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
266 [1] 266 💬 |
11 |
Kineret |
- |
- |
- |
- |
028 [9] 28, 41, 46, 49, 65, 106, 107, 266, 299 💬 |
12 |
One additional blood sample during a planned blood test |
- |
- |
- |
- |
266 [1] 266 💬 |
13 |
Other: colchicine cessation |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
14 |
Other: wheat flour |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
266 [1] 266 💬 |
15 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
16 |
Rilonacept |
Rilonacept |
[1] D06635 D06635 💬 |
IL1A [2] IL1A, IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [43] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
051 [4] 51, 106, 107, 266 💬 |
17 |
Roactemra |
- |
- |
- |
- |
040 [9] 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
18 |
Roactemra® 20mg/ml konzentrat |
- |
- |
- |
- |
266 [1] 266 💬 |
19 |
Tocilizumab |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
20 |
Tocilizumab infusion roacemtra (eu) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
266 [1] 266 💬 |
21 |
Wheat |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [2] 98, 266 💬 |